Polyarteritis nodosa (PAN) was first described in 1852 with the first widely recognised description in 1866 by Kussmaul and Meier. Since then our concepts of the condition have evolved, with recognition of the difference between polyarteritis nodosa and microscopic polyangiitis (MPA). Classification criteria for PAN remain unsatisfactory. The ACR criteria from 1990 did not recognise MPA or ANCA, with the result that their sensitivity and specificity are poor. The modern ACR/EULAR criteria as yet do not include PAN as yet. The aetiology is better understood, with recognition that hepatitis B associated PAN is a separate condition, discovery of genetic syndromes including DADA2 and VEXAS which can mimic PAN. Epidemiology suggests that PAN is becoming increasingly rare. Truly idiopathic PAN will gradually become a much rarer condition and may well disappear completely.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/rheumatology/keae649 | DOI Listing |
Rheumatology (Oxford)
March 2025
Norwich Medical School, University of East Anglia, Norwich, UK.
Polyarteritis nodosa (PAN) was first described in 1852 with the first widely recognised description in 1866 by Kussmaul and Meier. Since then our concepts of the condition have evolved, with recognition of the difference between polyarteritis nodosa and microscopic polyangiitis (MPA). Classification criteria for PAN remain unsatisfactory.
View Article and Find Full Text PDFRheumatology (Oxford)
March 2025
Division of Rheumatology, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Altindag, Ankara, Türkiye.
Polyarteritis Nodosa (PAN), is the firstly described vasculitis and can be seen in paediatric and adult age. PAN has a heterozygous clinical picture including cutaneous, constitutional, musculoskeletal, gastrointestinal, and renal involvement. Description and splitting of other vasculitis, makes this medium vessel vasculitis, a very rare disease.
View Article and Find Full Text PDFIntern Emerg Med
March 2025
Rheumatology Division, University Hospital Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
Aortitis and periaortitis refer to the inflammation of the aortic wall and the surrounding tissues. Both conditions are associated with various diseases and express nonspecific manifestations. Early diagnosis and treatment are crucial to improve the prognosis of the disease.
View Article and Find Full Text PDFOxf Med Case Reports
February 2025
Department of Rheumatology, NHO Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka 586-8521, Japan.
Polyarteritis nodosa (PAN) is systemic vasculitis, typically treated with a combination of glucocorticoids and immunosuppressants. Changing the immunosuppressant is recommended if remission cannot be achieved with these treatments. However, there is a lack of further treatment options for patients who are unresponsive to all immunosuppressants.
View Article and Find Full Text PDFPediatr Rheumatol Online J
February 2025
Department of Pediatrics, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, 589-8511, Japan.
Background: Fasciitis-panniculitis syndrome (FPS) typically presents with swelling and skin hardening. Its histopathological characteristics include inflammatory cell infiltration and fibrous thickening of the subcutaneous tissue and fascia. Panniculitides in children are rare and only a small number of juvenile FPS cases have been reported.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!